Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

New research urges reclassifying schizophrenia as a neurodevelopmental syndrome—advancing diagnosis, care, and public ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

One of the symptoms of schizophrenia is difficulty incorporating new information about the world. This can lead patients to struggle with making decisions and, eventually, to lose touch with reality.

Researchers found a grin2a mutation disrupts a brain circuit that updates beliefs using new information. In mice, restoring ...

Schizophrenia affects 1% of the global population and is caused by a complex interplay between at least 280 genes and environmental factors like childhood trauma and early cannabis use. Patients with ...

Researchers have found statistically significant links between a gene tied to schizophrenia risk and poorer cognitive ...

Schizoaffective disorder and schizophrenia have several symptoms in common, like hallucinations, delusions, and disorganized thinking or behavior. But although these conditions may resemble each other ...

Schizotypal personality disorder and schizophrenia have numerous similarities. However, both have differences in their symptoms and diagnostic criteria. Schizotypal personality disorder (STPD) and ...

Researchers have established an automated cage monitoring platform called IntelliCage to provide a naturalistic setting for assessing spontaneous mouse behaviors, improving preclinical models of ...